Skip to content

KNEIPP therapy for hypertension with special consideration of hydrotherapy in the home setting

KNEIPP therapy for hypertension with special consideration of hydrotherapy in the home setting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032851
Enrollment
100
Registered
2023-10-19
Start date
2023-06-05
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arterial hypertension (high normal, grade I, grade II)

Interventions

Group 1: Lifestyle advice and home-based hydrotherapy (KNEIPP) over 6 weeks Group 2: Lifestyle advice

Sponsors

Universität Witten/Herdecke, Gemeinschaftskrankenhaus Herdecke
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: arterial hypertension (high normal, grade I, grade II) in 24h blood pressure monitoring

Exclusion criteria

Exclusion criteria: pAVK IIb- IV Recent myocardial infarction in the last 6 months Chronic renal insufficiency from stage III onwards Cortisone therapy Advanced heart failure NYHA III and IV Unstable CHD Dementia Patients not able to give consent Advanced mobility impairment Pregnant women Acute severe infections Carrying out a fasting cure Not able to speak German Patients who regularly perform Kneipp treatments

Design outcomes

Primary

MeasureTime frame
Change in systolic blood pressure in 24h blood pressure monitoring after 6 weeks

Secondary

MeasureTime frame
- Change in arterial age in 24h blood pressure monitoring after 6 weeks - Change in systolic blood pressure in 24h blood pressure monitoring after 3 and 12 weeks (only interventional group) - Change in diastolic blood pressure in 24h blood pressure monitoring after 6 weeks - Change in quality of life after 6 weeks - Compliance of hydrotherapy in the home setting

Countries

Germany

Contacts

Public ContactKatja Gündling

Praxis Gündling

Katja.Guendling@gmx.de+49 6434 4946

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026